phase readout
saveNCT06666348: Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: St. Justine's Hospital. Phase: PHASE1. Conditions: Pediatric Low-grade Glioma
view source ↗
comments(0)
5-min edit window · permanent after that